Patients Come First has released new polling on the impact of legal advertisements and the risks they pose to patients. These ads can lead individuals to make dangerous health decisions—such as stopping prescribed treatments. To better protect Americans, stronger oversight and

A new Patients Come First poll shows 66% of Americans believe legal ads cause patients to fear safe medications—highlighting widespread concern over lawsuit-driven drug ads. Read more: patientscomefirst.com/news/press-rel…

ICYMI: A new Patients Come First poll reveals how legal ads mislead patients and drive risky health decisions. Read more: patientscomefirst.com/news/press-rel…

According to our new poll, 87% of Americans support requiring legal ads about prescription drugs to include a clear disclaimer urging patients to consult their doctors before stopping medication. See more results on how these ads can mislead patients and consumers here:

DYK: Only 19% of Americans surveyed are very confident that law firm ads about medications provide balanced, science-based information. See the full results here: patientscomefirst.com/news/legal-ad-…

Stronger oversight of legal advertising for medical products is essential to protect patient safety. Our new poll reveals how these ads can mislead patients and prompt them to stop taking medications without consulting their doctors. See the full results here:

Patients should make decisions about their medications with guidance from their doctors—not from legal ads designed to fuel lawsuits. Our new poll highlights how these ads spread misinformation and put patient safety at risk. Learn more here: patientscomefirst.com/news/press-rel…

Patients Come First’s new poll shows how legal ads can mislead patients and put their safety at risk. See the results here: patientscomefirst.com/news/legal-ad-…

In response to the new 340B Rebate Pilot Program, PCF submitted a comment to HRSA underscoring the strong step forward these reforms represent. Read the comment: patientscomefirst.com/news/comment-o…

ICYMI: PCF submitted a comment on the new 340B Rebate Pilot Program—a step in the right direction, but more work lies ahead. Read the full comment: patientscomefirst.com/news/comment-o…

Lawmakers must shift their focus from DTC ads to regulating trial lawyer advertising. Regulations for these harmful advertisements are essential to safeguarding public health. Learn more: realclearhealth.com/2025/09/16/new…

NEW OP-ED: National Spokesperson Kasia Mulligan on Donald J. Trump’s EO addressing direct-to-consumer ads and why lawmakers must prioritize reining in misleading legal advertising. Read more: realclearhealth.com/2025/09/16/new…

What would you do if you saw an ad claiming that the medication you take daily is dangerous? Patients Come First argues that Trump's recent Executive Order on direct-to-consumer (DTC) ads from pharmaceutical companies rings hollow if the Administration overlooks an even more harmful

PCF National Spokesperson Kasia Mulligan's new op-ed in The Well News sheds light on the broken 340B program and how it's strayed from its original intent—helping patients find lower-cost care. Read more: thewellnews.com/in-the-news/ra…

.PatientsComeFirstNJ's ED new op-ed in ROI-NJ underscores why lawmakers must reform the 340B Program to prioritize patients over profits. Read more: patientscomefirst.com/news/roi-nj-co…

"Congress has a moral and legislative responsibility to push forward and bring financial transparency, halt the misuse of funds, and restore trust and integrity to a vital program that has lost its way." Read more from National Spokesperson Kasia Mulligan: thewellnews.com/in-the-news/ra…

A new op-ed from PCF National Spokesperson Kasia Mulligan outlines the urgent need for lawmakers to rein in trial lawyer advertising and highlights the public health risk they pose. Read more: dcjournal.com/the-health-wis…

In a new op-ed, PatientsComeFirstNJ Executive Director warns that junk science is enabling trial lawyers to override medical expertise in health care decisions, putting patients at risk. Read more: patientscomefirst.com/news/northjers…